Jaffar M Khan1, Vasilis C Babaliaros2, Adam B Greenbaum3, Jason R Foerst4, Shahram Yazdani5, James M McCabe6, Gaetano Paone7, Marvin H Eng7, Bradley G Leshnower2, Patrick T Gleason2, Marcus Y Chen1, Dee Dee Wang7, Xin Tian8, Annette M Stine1, Toby Rogers9, Robert J Lederman10. 1. Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. 2. Structural Heart and Valve Center, Emory University Hospital, Atlanta, Georgia. 3. Structural Heart and Valve Center, Emory University Hospital, Atlanta, Georgia; Center for Structural Heart Disease, Division of Cardiology, and Division of Cardiac Surgery, Henry Ford Health System, Detroit, Michigan. 4. Carilion Roanoke Memorial Hospital, Roanoke, Virginia. 5. Inova Fairfax Hospital, Fairfax, Virginia. 6. University of Washington, Seattle, Washington. 7. Center for Structural Heart Disease, Division of Cardiology, and Division of Cardiac Surgery, Henry Ford Health System, Detroit, Michigan. 8. Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. 9. Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland; Medstar Washington Hospital Center, Washington, DC. 10. Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: lederman@nih.gov.
Abstract
BACKGROUND: Left ventricular outflow tract (LVOT) obstruction is a leading cause of mortality and exclusion from transcatheter mitral valve replacement (TMVR). Intentional laceration of the anterior mitral valve leaflet to prevent LVOT obstruction (LAMPOON) is a transcatheter mimic of surgical chord-sparing leaflet resection. OBJECTIVES: The purpose of this prospective multicenter trial was to study LAMPOON with transseptal (Edwards Lifesciences, Irvine, California) TMVR in annuloplasty rings or native mitral annular calcification (MAC). METHODS: Subjects at high or extreme surgical risk and prohibitive risk of LVOT obstruction from TMVR were included. Eligibility was modified midtrial to exclude subjects with threatened LVOT obstruction from a Sapien 3 valve fabric skirt. The primary endpoint was procedure survival with successful LAMPOON, with successful TMVR, without reintervention, and with LVOT gradient <30 mm Hg ("optimal") or <50 mm Hg ("acceptable"). Secondary endpoints included 30-day mortality and major adverse cardiovascular events. There was universal source-data verification and independent monitoring. All endpoints were independently adjudicated. Central laboratories analyzed echocardiogram and CT images. RESULTS: Between June 2017 and June 2018, 30 subjects were enrolled equally between the MAC and ring arms. LAMPOON traversal and midline laceration was successful in 100%. Procedure survival was 100%, and 30-day survival was 93%. Primary success was achieved in 73%, driven by additional procedures for paravalvular leak (10%) and high-skirt neo-LVOT gradients observed before a protocol amendment. There were no strokes. CONCLUSIONS: LAMPOON was feasible in native and annuloplasty ring anatomies in patients who were otherwise ineligible for treatment, with acceptable safety. LAMPOON was effective in preventing LVOT obstruction from TMVR. Despite LAMPOON, TMVR using Sapien 3 in annuloplasty rings and MAC still exhibits important limitations. (NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation; NCT03015194). Published by Elsevier Inc.
BACKGROUND:Left ventricular outflow tract (LVOT) obstruction is a leading cause of mortality and exclusion from transcatheter mitral valve replacement (TMVR). Intentional laceration of the anterior mitral valve leaflet to prevent LVOT obstruction (LAMPOON) is a transcatheter mimic of surgical chord-sparing leaflet resection. OBJECTIVES: The purpose of this prospective multicenter trial was to study LAMPOON with transseptal (Edwards Lifesciences, Irvine, California) TMVR in annuloplasty rings or native mitral annular calcification (MAC). METHODS: Subjects at high or extreme surgical risk and prohibitive risk of LVOT obstruction from TMVR were included. Eligibility was modified midtrial to exclude subjects with threatened LVOT obstruction from a Sapien 3 valve fabric skirt. The primary endpoint was procedure survival with successful LAMPOON, with successful TMVR, without reintervention, and with LVOT gradient <30 mm Hg ("optimal") or <50 mm Hg ("acceptable"). Secondary endpoints included 30-day mortality and major adverse cardiovascular events. There was universal source-data verification and independent monitoring. All endpoints were independently adjudicated. Central laboratories analyzed echocardiogram and CT images. RESULTS: Between June 2017 and June 2018, 30 subjects were enrolled equally between the MAC and ring arms. LAMPOON traversal and midline laceration was successful in 100%. Procedure survival was 100%, and 30-day survival was 93%. Primary success was achieved in 73%, driven by additional procedures for paravalvular leak (10%) and high-skirt neo-LVOT gradients observed before a protocol amendment. There were no strokes. CONCLUSIONS: LAMPOON was feasible in native and annuloplasty ring anatomies in patients who were otherwise ineligible for treatment, with acceptable safety. LAMPOON was effective in preventing LVOT obstruction from TMVR. Despite LAMPOON, TMVR using Sapien 3 in annuloplasty rings and MAC still exhibits important limitations. (NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation; NCT03015194). Published by Elsevier Inc.
Authors: David W M Muller; Robert Saeid Farivar; Paul Jansz; Richard Bae; Darren Walters; Andrew Clarke; Paul A Grayburn; Robert C Stoler; Gry Dahle; Kjell A Rein; Marty Shaw; Gregory M Scalia; Mayra Guerrero; Paul Pearson; Samir Kapadia; Marc Gillinov; Augusto Pichard; Paul Corso; Jeffrey Popma; Michael Chuang; Philipp Blanke; Jonathon Leipsic; Paul Sorajja Journal: J Am Coll Cardiol Date: 2016-12-28 Impact factor: 24.094
Authors: William A Zoghbi; John B Chambers; Jean G Dumesnil; Elyse Foster; John S Gottdiener; Paul A Grayburn; Bijoy K Khandheria; Robert A Levine; Gerald Ross Marx; Fletcher A Miller; Satoshi Nakatani; Miguel A Quiñones; Harry Rakowski; L Leonardo Rodriguez; Madhav Swaminathan; Alan D Waggoner; Neil J Weissman; Miguel Zabalgoitia Journal: J Am Soc Echocardiogr Date: 2009-09 Impact factor: 5.251
Authors: Vasilis C Babaliaros; Adam B Greenbaum; Jaffar M Khan; Toby Rogers; Dee Dee Wang; Marvin H Eng; William W O'Neill; Gaetano Paone; Vinod H Thourani; Stamatios Lerakis; Dennis W Kim; Marcus Y Chen; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2017-04-24 Impact factor: 11.195
Authors: Pierre Deharo; Marina Urena; Dominique Himbert; Eric Brochet; Frederic Rouleau; Frederic Pinaud; Stephane Delepine; Jose Luis Carrasco; Walid Ghodbane; Fabrice Extramiana; Phalla Ou; Marie Pierre Dilly; David Messika-Zeitoun; Bernard Iung; Patrick Nataf; Alec Vahanian Journal: JACC Cardiovasc Interv Date: 2016-03-23 Impact factor: 11.195
Authors: Gregg W Stone; David H Adams; William T Abraham; Arie Pieter Kappetein; Philippe Généreux; Pascal Vranckx; Roxana Mehran; Karl-Heinz Kuck; Martin B Leon; Nicolo Piazza; Stuart J Head; Gerasimos Filippatos; Alec S Vahanian Journal: J Am Coll Cardiol Date: 2015-07-21 Impact factor: 24.094
Authors: Jaffar M Khan; Toby Rogers; William H Schenke; Jonathan R Mazal; Anthony Z Faranesh; Adam B Greenbaum; Vasilis C Babaliaros; Marcus Y Chen; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2016-09-12 Impact factor: 11.195
Authors: Keshav Kohli; Zhenglun Alan Wei; Vahid Sadri; Tiffany Netto; John C Lisko; Adam B Greenbaum; Vasilis Babaliaros; John N Oshinski; Ajit P Yoganathan Journal: Ann Biomed Eng Date: 2021-03-15 Impact factor: 3.934
Authors: Jaffar M Khan; Vasilis C Babaliaros; Adam B Greenbaum; Toby Rogers; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2019-09-23 Impact factor: 11.195
Authors: Brian Whisenant; Samir R Kapadia; Mackram F Eleid; Susheel K Kodali; James M McCabe; Amar Krishnaswamy; Michael Morse; Richard W Smalling; Mark Reisman; Michael Mack; William W O'Neill; Vinayak N Bapat; Martin B Leon; Charanjit S Rihal; Raj R Makkar; Mayra Guerrero Journal: JAMA Cardiol Date: 2020-11-01 Impact factor: 14.676
Authors: John C Lisko; Adam B Greenbaum; Robert J Lederman; Vasilis C Babaliaros; Jaffar M Khan; Norihiko Kamioka; Patrick T Gleason; Isida Byku; Jose F Condado; Andres Jadue; Gaetano Paone; Kendra J Grubb; Jasleen Tiwana; James M McCabe; Toby Rogers Journal: Circ Cardiovasc Interv Date: 2020-06-09 Impact factor: 6.546
Authors: John C Lisko; Adam B Greenbaum; Robert A Guyton; Norihiko Kamioka; Kendra J Grubb; Patrick T Gleason; Isida Byku; Jose F Condado; Andres Jadue; Gaetano Paone; Peter C Block; Lucia Alvarez; Joe Xie; Jaffar M Khan; Toby Rogers; Robert J Lederman; Vasilis C Babaliaros Journal: JACC Cardiovasc Interv Date: 2020-09-30 Impact factor: 11.195
Authors: Jaffar M Khan; Toby Rogers; Adam B Greenbaum; Vasilis C Babaliaros; Dursun Korel Yildirim; Christopher G Bruce; Daniel A Herzka; William H Schenke; Kanishka Ratnayaka; Robert J Lederman Journal: J Am Coll Cardiol Date: 2020-03-31 Impact factor: 24.094
Authors: John C Lisko; Vasilis C Babaliaros; Jaffar M Khan; Norihiko Kamioka; Patrick T Gleason; Gaetano Paone; Isida Byku; Jasleen Tiwana; James M McCabe; Krishna Cherukuri; Ramzi Khalil; David Lasorda; Sachin S Goel; Neal S Kleiman; Michael J Reardon; David V Daniels; Christian Spies; Paul Mahoney; Brian C Case; Brian K Whisenant; Pradeep K Yadav; Jose F Condado; Rachel Koch; Kendra J Grubb; Christopher G Bruce; Toby Rogers; Robert J Lederman; Adam B Greenbaum Journal: JACC Cardiovasc Interv Date: 2021-03-01 Impact factor: 11.195
Authors: Ralf Sodian; Michael Kruttschnitt; Niklas Hitschrich; Bernhard Mumm; Christian Schnell; Christian Hagl; Nikolaus Thierfelder; Fabian König Journal: Interact Cardiovasc Thorac Surg Date: 2021-05-10